The public registers hold a second record for KRKA,d.d.,Novo mesto. The fuller profile, with 0 active US DMFs and 37 valid CEPs, is at Krka. Figures on this page cover only this record.
KRKA,d.d.,Novo mesto is an API and finished-dose manufacturer based in Slovenia. It appears in 4,865 regulatory filings across 16 regulators, without an active US DMF or CEP on file. Its filings concentrate with AIFA (IT), FAMHP (BE) and AEMPS (ES).
| Site | FDA FEI |
|---|---|
| Novo mesto, United Arab Emirates | Not on file |
| Molecule | Regulators | Docs |
|---|---|---|
| Etoricoxib | SFDA (Saudi Arabia) | 1 |
| Memantine | SFDA (Saudi Arabia) | 1 |
| Pantoprazole | SFDA (Saudi Arabia) | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| AIFA (IT) | 2,195 | None |
| FAMHP (BE) | 713 | None |
| AEMPS (ES) | 519 | None |
| MPA (SE) | 493 | None |
| INFARMED (PT) | 438 | None |
| RCETH (BY) | 139 | None |
Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.
Ask Fred what the record holds on KRKA,d.d.,Novo mesto, including filings and inspection history.
Chat with Fred, your AI analystRanked by shared active ingredients where we have them, otherwise by country and comparable credentials.